Upload Image (Max 20MB per Image)
Clinigen Group and Theravance have signed an exclusive commercialization agreement for Vibativ (telavancin) in the EU and few other countries located in Europe. The bactericidal, once-daily injectable lipoglycopeptide antibacterial agent ...
Tags: Clinigen, Theravance, Vibativ commercialization